Global Constipation Treatment Market is Expected to Grow at a Healthy CAGR

Constipation Treatment Market Size and Forecast

Constipation Treatment Market size was valued at USD 19.88 Billion in 2024 and is projected to reach USD 33.57 Billion by 2031, growing at a CAGR of 6.77% from 2024 to 2031.

• Constipation treatment consists of a variety of procedures designed to help people pass stool more easily and consistently. For moderate cases, simple lifestyle modifications might have a big effect. Increased fiber intake from fruits, vegetables, whole grains, and legumes can help to bulk up stool and make it easier to pass. Drinking enough of water is also beneficial because it softens the stool. Regular physical activity such as walking or other forms of exercise promotes bowel movement.
• Constipation treatment includes a variety of applications targeted at improving the discomfort and health problems caused by infrequent or difficult bowel motions. One of the main therapies is the use of over-the-counter laxatives. These drugs encourage bowel motions by softening the stool or boosting intestinal spasms.
• Constipation treatment will likely become more individualized and successful in the future as medical research and technology develop. One significant breakthrough projected is the use of personalized medicine which tailors therapies to an individual’s genetic composition, lifestyle, and specific health concerns.

Global Constipation Treatment Market Dynamics

The key market dynamics that are shaping the global constipation treatment market include:

Key Market Drivers:

• Aging Population: One of the key drivers of the constipation treatment industry is the expanding elderly population. Constipation is more common as people get older because their digestive systems slow down. Older folks frequently lead sedentary lifestyles, consume less fiber, and may take drugs that contribute to constipation.
• Increasing Awareness and Health Education: People are becoming more aware of digestive health and the need to treat constipation as soon as possible. Governments and healthcare groups have conducted educational campaigns and health efforts to raise public awareness of the signs and effects of untreated constipation. Improved health literacy encourages people to seek medical advice and treatment which drives up demand for constipation relief goods and drugs.
• Lifestyle Changes: Modern lives marked by poor food habits, a lack of physical activity, and high levels of stress all contribute considerably to the prevalence of constipation. Many urban areas have low-fiber, high-processed-food diets as well as poor water intake. Furthermore, sedentary work settings and demanding schedules leave little time for regular exercise worsening the problem.

Key Challenges:

• Variable Causes and Individual Differences: Diet, lifestyle, drugs, and underlying health issues can all contribute to constipation. This heterogeneity makes it difficult to find a one-size-fits-all remedy. Constipation can be caused by a low-fiber, low-fluid diet as well as certain drugs such as pain relievers or antidepressants.
• Side Effects of Drugs: While there are numerous drugs available to treat constipation, they frequently have negative side effects. Common over-the-counter treatments such as laxatives can cause discomfort, diarrhoea, and dependence if used in excess. Prescription drugs may be more successful in extreme situations but they can cause serious adverse effects such as nausea, stomach pain, and electrolyte imbalances.
• Underreporting and Stigma: Constipation is a condition that many individuals are embarrassed to discuss resulting in underreporting. Patients may be hesitant to communicate their concerns with healthcare providers or wait to seek treatment until the issue worsens. The stigma associated with intestinal health can inhibit early and efficient treatment.

Key Trends:

• Focus on Lifestyle Modifications: One notable trend in constipation therapy is a greater emphasis on lifestyle adjustments as the primary technique. Healthcare practitioners are increasingly recommending dietary changes such as boosting fiber consumption from fruits, vegetables, and whole grains as well as staying hydrated. Regular physical activity is also recommended because it promotes bowel motions and improves overall digestive health.
• Rise in Over-the-counter (OTC) Medicines: Another notable trend is the increased use of over-the-counter (OTC) medicines for constipation alleviation. Individuals seeking immediate relief from occasional constipation frequently utilize over-the-counter laxatives, stool softeners, and fiber supplements. These products are typically useful for the self-management of mild to moderate symptoms eliminating the need for prescription drugs or medical intervention.
• Advancements in Prescription Drugs: While many cases of constipation can be treated with over-the-counter drugs, there is a trend toward the development of advanced prescription medications for more severe or chronic constipation. These drugs may include osmotic laxatives, prokinetic agents, and other targeted therapies designed to increase bowel motility or shorten colonic transit time.

Global Constipation Treatment Market Regional Analysis

Here is a more detailed regional analysis of the global constipation treatment market:

North America:

• The constipation treatment market in North America is rapidly expanding with the United States leading the way in terms of size and innovation. This expansion is mostly driven by an older population and the rising prevalence of gastrointestinal illnesses.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reports that roughly 16% of adults in the United States suffer from constipation symptoms. This corresponds to around 42 million people indicating a large market opportunity for constipation therapies.
• According to the American Gastroenterological Association, constipation has a significant economic impact in the United States, with direct and indirect expenditures estimated to be more than $230 million yearly. This financial burden provides a tremendous incentive for the development of new and improved constipation treatment options.
• According to the Canadian Society of Intestinal Research, roughly 15-20% of Canadians suffer from chronic constipation which is consistent with U.S. numbers and indicates a potential market opportunity in Canada. In recent years, Health Canada has approved several new constipation medicines demonstrating increased demand and regulatory support for innovative therapies in this field. According to the Centers for Disease Control and Prevention (CDC), constipation accounts for over 2.5 million physician office visits yearly in the United States highlighting the strain on healthcare systems and the need for effective treatments.

Asia Pacific:

• The Asia Pacific region’s constipation treatment industry is rapidly expanding with China and India emerging as the fastest-growing countries in this sector. This expansion is mostly driven by increase in knowledge of digestive health changing dietary choices, and an aging population. The World Gastroenterology Organisation reports that constipation affects 10% to 20% of the Asian population. In China, research published in the Journal of Neurogastroenterology and Motility discovered that functional constipation affected around 6% of the general population.
• According to the Indian Journal of Gastroenterology, the prevalence of constipation in the general population is between 8% and 12% with greater rates seen in metropolitan areas. The World Health Organization (WHO) predicts that the proportion of the Asia Pacific population aged 60 and up will double from 12.5% in 2020 to 24.6% by 2050, potentially increasing the incidence of constipation. Lifestyle and food choices have a significant impact on the Asia Pacific constipation treatment industry. A study published in the Asia Pacific Journal of Clinical Nutrition discovered that poor dietary fiber intake is typical in many Asian countries with average consumption frequently falling below the recommended 20-25 grams per day.

Global Constipation Treatment Market: Segmentation Analysis

The Global Constipation Treatment Market is segmented based on Type of Treatment, Route of Administration, Patient Age Group, and Geography.

Constipation Treatment Market, By Type of Treatment

• Pharmaceutical Treatment
• Non-pharmaceutical Treatment

Based on the Type of Treatment, the Global Constipation Treatment Market is bifurcated into Pharmaceutical Treatment and Non-Pharmaceutical Treatment. In the global constipation treatment market, pharmaceutical treatments currently dominate over non-pharmaceutical treatments. This dominance is primarily driven by the effectiveness and immediate relief provided by pharmaceutical options such as laxatives, stool softeners, and prescription medications. Pharmaceutical treatments are often preferred for their ability to target specific symptoms and provide quick results making them suitable for managing both acute and chronic cases of constipation.

Constipation Treatment Market, By Route of Administration

• Oral
• Rectal

Based on the Route of Administration, the Global Constipation Treatment Market is bifurcated into Oral and Rectal. In the constipation treatment market, the oral route of administration tends to dominate over the rectal route. This dominance is primarily due to several factors. Oral medications such as laxatives and stool softeners are widely preferred due to their convenience, ease of administration, and patient acceptance. They offer a non-invasive treatment option that can be self-administered at home making them more accessible and practical for long-term management of constipation.

Constipation Treatment Market, By Patient Age Group

• Adults
• Pediatrics

Based on the Patient Age Group, the Global Constipation Treatment Market is bifurcated into Adults and Pediatrics. In the global constipation treatment market, adults dominate over pediatrics. This dominance is primarily driven by several factors. Constipation is more prevalent among adults due to lifestyle factors such as poor diet, lack of physical activity, and certain medications that can contribute to bowel irregularity. Adults also have a higher incidence of chronic conditions like irritable bowel syndrome (IBS) and neurological disorders which can exacerbate constipation and require ongoing management.

Constipation Treatment Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Constipation Treatment Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In the constipation treatment market, North America holds dominance due to several factors. It has a well-established healthcare infrastructure with high levels of awareness and accessibility to advanced medical treatments. The region also sees a significant prevalence of lifestyle-related disorders contributing to a higher demand for constipation treatments. Moreover, robust research and development activities by pharmaceutical companies in North America lead to continuous innovations in treatment options including both pharmaceutical and non-pharmaceutical approaches.

Key Players

The “Global Constipation Treatment Market” study report will provide valuable insight with an emphasis on the global market.  The major players in the market are Takeda Pharmaceutical Company Ltd., Ironwood Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Abbott Laboratories, AstraZeneca Plc, Cosmo Pharmaceuticals NV, Sanofi S.A., Bayer AG, Valeant Pharmaceuticals International, Inc., and Pfizer, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Constipation Treatment Market Key Developments

• In May 2022, EA Pharma and Mochida Pharmaceutical introduced ‘MOVICOL HD’, a chronic constipation therapy, in Japan.
• In April 2022, Ardelyx, Inc. gained IBSRELA approval from the US Food and Drug Administration (USFDA). This is an NHE3 inhibitor used to treat IBS-C in adults.

Report Scope

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report:

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any